NOT-HL-19-740: Notice of Correction to application submission information for NOT-HL-19-724 "Notice of Special Interest (NOSI): Availability of Administrative and Revision Supplements to Expand Vaping Research and Understand EVALI"

Notice of Correction to application submission information for NOT-HL-19-724 "Notice of Special Interest (NOSI): Availability of Administrative and Revision Supplements to Expand Vaping Research and Understand EVALI"

Notice Number: NOT-HL-19-740

Key Dates
Release Date: December 19, 2019

Related Announcements
NOT-HL-19-724

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

On November 6, 2019, the National Heart, Lung, and Blood Institute (NHLBI) published NOT-HL-19-724 "Notice of Special Interest (NOSI): Availability of Administrative and Revision Supplements to Expand Vaping Research and Understand EVALI." The purpose of this Notice is to specify that electronic submission is required for this NOSI and to clarify the correct application form package to use when submitting.

The following instructions areappended to the bulleted listlocated at then end of the Application and Submission Information section of NOT-HL-19-724:

All applications (including those for multi-project activity codes) must be submitted electronically using a single-project application form package
- Administrative supplement applications to PA-18-591 must use the application form package with the Competition ID of “FORMS-E-ADMINSUPP-RESEARCH”
- Competitive revision applications to PA-18-935 must use the application form package with the Competition ID of “NOT-HL-19-724-FORMS-E”

All other aspects of this NOSI remain unchanged.

Inquiries

Please direct all inquiries to:

Lisa Postow, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-7843
Email: [email protected]